Hepatitis B virus-induced hepatocellular carcinoma

Cancer Letters

Volumn 345, Issue 2, 2014, Pages 216-222

  Xu, Cheng ^a   Zhou, Wence ^b   Wang, Yuming ^a   Qiao, Liang ^c  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Carcinogenesis; HBV; HBVx; HCC

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS X PROTEIN; MESSENGER RNA; MICRORNA; THYMINE DNA GLYCOSYLASE; VIRUS DNA;

APOPTOSIS; CELL PROLIFERATION; EPIGENETICS; HEPATITIS B VIRUS; HEPATITIS C; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURAL HOMOLOGY; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS MUTATION;

HEPATITIS B VIRUS;

CARCINOGENESIS; HBV; HBVX; HCC;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, VIRAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INFLAMMATION MEDIATORS; LIVER NEOPLASMS; PROGNOSIS; RISK FACTORS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84896740011     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.08.035     Document Type: Review

References (100)

1. Nordenstedt H., White D.L., El-Serag H.B. The changing pattern of epidemiology in hepatocellular carcinoma. Dig. Liver Dis. 2010, 42(Suppl. 3):S206-S214.
2. Yang H.I., Yuen M.F., Chan H.L., Han K.H., Chen P.J., Kim D.Y., Ahn S.H., Chen C.J., Wong V.W., Seto W.K. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet. Oncol. 2011, 12:568-574.
3. Nguyen V.T., Law M.G., Dore G.J. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J. Viral Hepat. 2009, 16:453-463.
4. Iloeje U.H., Yang H.I., Chen C.J. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?. Liver Int. 2012, 32:1333-1341.
5. Kim C.M., Koike K., Saito I., Miyamura T., Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991, 351:317-320.
6. Koike K., Moriya K., Iino S., Yotsuyanagi H., Endo Y., Miyamura T., Kurokawa K. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 1994, 19:810-819.
7. Lakhtakia R., Kumar V., Reddi H., Mathur M., Dattagupta S., Panda S.K. Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: a sequential pathological evaluation. J. Gastroenterol. Hepatol. 2003, 18:80-91.
8. Wang Y., Cui F., Lv Y., Li C., Xu X., Deng C., Wang D., Sun Y., Hu G., Lang Z., Huang C., Yang X. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 2004, 39:318-324.
9. * mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. BMC Cancer 2011, 11:398.
10. Lai M.W., Yeh C.T. The oncogenic potential of hepatitis B virus rtA181T/surface truncation mutant. Antivir. Ther. 2008, 13:875-879.
11. * mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 2008, 48:88-98.
12. * mutant strain of hepatitis B virus in animal model. J. Virol. 2012, 9:280.
13. Wang Z., Tanaka Y., Huang Y., Kurbanov F., Chen J., Zeng G., Zhou B., Mizokami M., Hou J. Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China. J. Clin. Microbiol. 2007, 45:1491-1496.
14. Rahmani Z., Huh K.W., Lasher R., Siddiqui A. Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J. Virol. 2000, 74:2840-2846.
15. Henkler F., Hoare J., Waseem N., Goldin R.D., McGarvey M.J., Koshy R., King I.A. Intracellular localization of the hepatitis B virus HBx protein. J. Gen. Virol. 2001, 82:871-882.
16. Kim S., Kim H.Y., Lee S., Kim S.W., Sohn S., Kim K., Cho H. Hepatitis B virus X protein induces perinuclear mitochondrial clustering in microtubule - and dynein-dependent manners. J. Virol. 2007, 81:1714-1726.
17. Clippinger A.J., Bouchard M.J. Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. J. Virol. 2008, 82:6798-6811.
18. Keasler V.V., Hodgson A.J., Madden C.R., Slagle B.L. Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamically-injected mice. Virology 2009, 390:122-129.
19. Chan C., Wang Y., Chow P.K., Chung A.Y., Ooi L.L., Lee C.G. Altered binding site selection of p53 transcription cassettes by hepatitis B virus X protein. Mol. Cell. Biol. 2013, 33:485-497.
20. Cho I.R., Oh M., Koh S.S., Malilas W., Srisuttee R., Jhun B.H., Pellegrini S., Fuchs S.Y., Chung Y.H. Hepatitis B virus X protein inhibits extracellular IFN-alpha-mediated signal transduction by down-regulation of type I IFN receptor. Int. J. Mol. Med. 2012, 29:581-586.
21. Hernandez S., Venegas M., Brahm J., Villanueva R.A. The viral transactivator HBx protein exhibits a high potential for regulation via phosphorylation through an evolutionarily conserved mechanism. Infect Agent Cancer 2012, 7:27.
22. Toh S.T., Jin Y., Liu L., Wang J., Babrzadeh F., Gharizadeh B., Ronaghi M., Toh H.C., Chow P.K., Chung A.Y., Ooi L.L., Lee C.G. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations. Carcinogenesis 2013, 34:787-798.
23. Luo N., Cai Y., Zhang J., Tang W., Slagle B.L., Wu X., He S. The C-terminal region of the hepatitis B virus X protein is required for its stimulation of HBV replication in primary mouse hepatocytes. Virus Res. 2012, 165:170-178.
24. Jung S.Y., Kim Y.J. C-terminal region of HBx is crucial for mitochondrial DNA damage. Cancer Lett. 2013, 331:76-83.
25. Sze K.M., Chu G.K., Lee J.M., Ng I.O. C-terminal truncated hepatitis B virus X protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 2013, 57:131-139.
26. Liu L., Li Y., Zhang S., Yu D., Zhu M. Hepatitis B virus X protein mutant upregulates CENP - a expression in hepatoma cells. Oncol. Rep. 2012, 27:168-173.
27. Yip W.K., Cheng A.S., Zhu R., Lung R.W., Tsang D.P., Lau S.S., Chen Y., Sung J.G., Lai P.B., Ng E.K., Yu J., Wong N., To K.F., Wong V.W., Sung J.J., Chan H.L. Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development. PLoS One 2011, 6:e22888.
28. van de Klundert M.A., van Hemert F.J., Zaaijer H.L., Kootstra N.A. The hepatitis B virus X protein inhibits thymine DNA glycosylase initiated base excision repair. PLoS One 2012, 7:e48940.
29. Zhang T., Zhang J., You X., Liu Q., Du Y., Gao Y., Shan C., Kong G., Wang Y., Yang X., Ye L., Zhang X. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology 2012, 56:2051-2059.
30. Srisuttee R., Koh S.S., Malilas W., Moon J., Cho I.R., Jhun B.H., Horio Y., Chung Y.H. SIRT1 sensitizes hepatocellular carcinoma cells expressing hepatitis B virus X protein to oxidative stress-induced apoptosis. Biochem. Biophys. Res. Commun. 2012, 429:45-50.
31. Srisuttee R., Koh S.S., Kim S.J., Malilas W., Boonying W., Cho I.R., Jhun B.H., Ito M., Horio Y., Seto E., Oh S., Chung Y.H. Hepatitis B virus X (HBX) protein upregulates beta-catenin in a human hepatic cell line by sequestering SIRT1 deacetylase. Oncol. Rep. 2012, 28:276-282.
32. Khattar E., Mukherji A., Kumar V. Akt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylation. FEBS J. 2012, 279:1220-1230.
33. Lv W.P., Zhou K.L., Gao B., Chen Y.L., Xiang X., Su M., Dong J.H. Hepatitis B virus X protein induces malignant transformation tendency of Chang liver cells involving p16(INK4a) hypermethylation. Beijing Da Xue Xue Bao 2012, 44:932-936.
34. Wei X., Tan C., Tang C., Ren G., Xiang T., Qiu Z., Liu R., Wu Z. Epigenetic repression of miR-132 expression by the hepatitis B virus X protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal 2013, 25:1037-1043.
35. Huang Y., Tai A.W., Tong S., Lok A.S. HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription. J. Hepatol. 2013.
36. Liu H., Yuan Y., Guo H., Mitchelson K., Zhang K., Xie L., Qin W., Lu Y., Wang J., Guo Y., Zhou Y., He F. Hepatitis B virus encoded X protein suppresses apoptosis by inhibition of the caspase-independent pathway. J. Proteome. Res. 2012, 11:4803-4813.
37. Arzumanyan A., Sambandam V., Clayton M.M., Choi S.S., Xie G., Diehl A.M., Yu D.Y., Feitelson M.A. Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein. Cancer Res. 2012, 72:5912-5920.
38. Wang W., Zhou D., Wei J., Wu Z., Cheng X., Sun Q., Xie H., Zhou L., Zheng S. Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2012, 421:355-360.
39. Jiao B.Y., Lin W.S., She F.F., Chen W.N., Lin X. Hepatitis B virus X protein enhances activation of nuclear factor kappaB through interaction with valosin-containing protein. Arch. Virol. 2011, 156:2015-2021.
40. Li H., Wu K., Tao K., Chen L., Zheng Q., Lu X., Liu J., Shi L., Liu C., Wang G., Zou W. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology 2012, 56:1342-1351.
41. You X., Liu F., Zhang T., Lv N., Liu Q., Shan C., Du Y., Kong G., Wang T., Ye L., Zhang X. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells. Oncogene 2013.
42. Xu J., Liu H., Chen L., Wang S., Zhou L., Yun X., Sun L., Wen Y., Gu J. Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1. Gastroenterology 2012, 143:199-212 e194.
43. Wang F., Zhou H., Yang Y., Xia X., Sun Q., Luo J., Cheng B. Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the notch signaling pathway. Oncol. Rep. 2012, 27:1170-1176.
44. Tang R.X., Kong F.Y., Fan B.F., Liu X.M., You H.J., Zhang P., Zheng K.Y. HBx activates FasL and mediates HepG2 cell apoptosis through MLK3-MKK7-JNKs signal module. World J. Gastroenterol. 2012, 18:1485-1495.
45. Geng X., Harry B.L., Zhou Q., Skeen-Gaar R.R., Ge X., Lee E.S., Mitani S., Xue D. Hepatitis B virus X protein targets the Bcl-2 protein CED-9 to induce intracellular Ca2+ increase and cell death in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 2012, 109:18465-18470.
46. Lee W.P., Lan K.H., Li C.P., Chao Y., Lin H.C., Lee S.D. Pro-apoptotic or anti-apoptotic property of X protein of hepatitis B virus is determined by phosphorylation at Ser31 by Akt. Arch. Biochem. Biophys. 2012, 528:156-162.
47. Mao Y., Da L., Tang H., Yang J., Lei Y., Tiollais P., Li T., Zhao M. Hepatitis B virus X protein reduces starvation-induced cell death through activation of autophagy and inhibition of mitochondrial apoptotic pathway. Biochem. Biophys. Res. Commun. 2011, 415:68-74.
48. Liu H., Xu L., He H., Zhu Y., Liu J., Wang S., Chen L., Wu Q., Xu J., Gu J. Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing snail protein. Cancer Sci. 2012, 103:2072-2081.
49. Zhang S., Shan C., Cui W., You X., Du Y., Kong G., Gao F., Ye L., Zhang X. Hepatitis B virus X protein protects hepatoma and hepatic cells from complement-dependent cytotoxicity by up-regulation of CD46. FEBS Lett. 2013.
50. Xia L., Huang W., Tian D., Zhu H., Zhang Y., Hu H., Fan D., Nie Y., Wu K. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. J. Hepatol. 2012, 57:600-612.
51. Tang R., Kong F., Hu L., You H., Zhang P., Du W., Zheng K. Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells. Virol. J. 2012, 9:163.
52. Huang J.F., Guo Y.J., Zhao C.X., Yuan S.X., Wang Y., Tang G.N., Zhou W.P., Sun S.H. HBx-related lncRNA Dreh inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology 2012.
53. Du Y., Kong G., You X., Zhang S., Zhang T., Gao Y., Ye L., Zhang X. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J. Biol. Chem. 2012, 287:26302-26311.
54. Liu Y., Tong Z., Li T., Chen Q., Zhuo L., Li W., Wu R.C., Yu C. Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness. Hepatology 2012, 56:1015-1024.
55. Wei X., Xiang T., Ren G., Tan C., Liu R., Xu X., Wu Z. MiR-101 is down-regulated by the hepatitis B virus X protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal 2013, 25:439-446.
56. Fu X., Tan D., Hou Z., Hu Z., Liu G. MiR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3'-UTR region of cyclinD1. Int. J. Mol. Sci. 2012, 13:8514-8539.
57. Xu Y., Yang Y., Cai Y., Liu F., Liu Y., Zhu Y., Wu J. The X protein of hepatitis B virus activates hepatoma cell proliferation through repressing melanoma inhibitory activity 2 gene. Biochem. Biophys. Res. Commun. 2011, 416:379-384.
58. Xu X., Fan Z., Kang L., Han J., Jiang C., Zheng X., Zhu Z., Jiao H., Lin J., Jiang K., Ding L., Zhang H., Cheng L., Fu H., Song Y., Jiang Y., Liu J., Wang R., Du N., Ye Q. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J. Clin. Invest. 2013, 123:630-645.
59. Teng J., Wang X., Xu Z., Tang N. HBx-dependent activation of twist mediates STAT3 control of epithelium-mesenchymal transition of liver cells. J. Cell. Biochem. 2013, 114:1097-1104.
60. Wang L.H., Huang W., Lai M.D., Su I.J. Aberrant cyclin A expression and centrosome over-duplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis. Carcinogenesis 2012, 33:466-472.
61. Xiao C.X., Yang X.N., Huang Q.W., Zhang Y.Q., Lin B.Y., Liu J.J., Liu Y.P., Jazag A., Guleng B., Ren J.L. ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells. Cancer Lett. 2013, 330:67-73.
62. Liu Y.P., Yang X.N., Jazag A., Pan J.S., Hu T.H., Liu J.J., Guleng B., Ren J.L. HBsAg inhibits the translocation of JTB into mitochondria in HepG2 cells and potentially plays a role in HCC progression. PLoS One 2012, 7:e36914.
63. Hsieh Y.H., Su I.J., Yen C.J., Tsai T.F., Tsai H.W., Tsai H.N., Huang Y.J., Chen Y.Y., Ai Y.L., Kao L.Y., Hsieh W.C., Wu H.C., Huang W. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients. Carcinogenesis 2013, 34:475-485.
64. Li C., Wang Y., Wang S., Wu B., Hao J., Fan H., Ju Y., Ding Y., Chen L., Chu X., Liu W., Ye X., Meng S. Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J. Virol. 2013, 87:2193-2205.
65. Sung W.K., Zheng H., Li S., Chen R., Liu X., Li Y., Lee N.P., Lee W.H., Ariyaratne P.N., Tennakoon C., Mulawadi F.H., Wong K.F., Liu A.M., Poon R.T., Fan S.T., Chan K.L., Gong Z., Hu Y., Lin Z., Wang G., Zhang Q., Barber T.D., Chou W.C., Aggarwal A., Hao K., Zhou W., Zhang C., Hardwick J., Buser C., Xu J., Kan Z., Dai H., Mao M., Reinhard C., Wang J., Luk J.M. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 2012, 44:765-769.
66. Tao Y., Ruan J., Yeh S.H., Lu X., Wang Y., Zhai W., Cai J., Ling S., Gong Q., Chong Z., Qu Z., Li Q., Liu J., Yang J., Zheng C., Zeng C., Wang H.Y., Zhang J., Wang S.H., Hao L., Dong L., Li W., Sun M., Zou W., Yu C., Li C., Liu G., Jiang L., Xu J., Huang H., Mi S., Zhang B., Chen B., Zhao W., Hu S., Zhuang S.M., Shen Y., Shi S., Brown C., White K.P., Chen D.S., Chen P.J., Wu C.I. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc. Natl. Acad. Sci. USA 2011, 108:12042-12047.
67. Jiang Z., Jhunjhunwala S., Liu J., Haverty P.M., Kennemer M.I., Guan Y., Lee W., Carnevali P., Stinson J., Johnson S., Diao J., Yeung S., Jubb A., Ye W., Wu T.D., Kapadia S.B., de Sauvage F.J., Gentleman R.C., Stern H.M., Seshagiri S., Pant K.P., Modrusan Z., Ballinger D.G., Zhang Z. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome. Res. 2012, 22:593-601.
68. Zhu B.H., Wang L.T., Li T., Zhou B.P. Identification of HBx-related integration sites in HBsAg-positive hepatocellular carcinoma biopsy. Zhonghua Gan Zang Bing Za Zhi 2012, 20:468-471.
69. Cao Y., Bryan T.M., Reddel R.R. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci. 2008, 99:1092-1099.
70. Saigo K., Yoshida K., Ikeda R., Sakamoto Y., Murakami Y., Urashima T., Asano T., Kenmochi T., Inoue I. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Hum. Mutat. 2008, 29:703-708.
71. Pollicino T., Vegetti A., Saitta C., Ferrara F., Corradini E., Raffa G., Pietrangelo A., Raimondo G. Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. J. Hepatol. 2013, 58:190-193.
72. Zhang X., You X., Li N., Zhang W., Gagos S., Wang Q., Banos A., Cai N., Zhang H., Shan C., Qiu L., Zhang S., Lv N., Chen M., Du Y., Xia J., Ye L. Involvement of hepatitis B virus X gene (HBx) integration in hepatocarcinogenesis via a recombination of HBx/Alu core sequence/subtelomeric DNA. FEBS Lett. 2012, 586:3215-3221.
73. Ortiz-Cuaran S., Villar S., Gouas D., Ferro G., Plymoth A., Khuhaprema T., Kalalak A., Sangrajrang S., Friesen M.D., Groopman J.D., Hainaut P. Association between HBx status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand. Cancer Lett. 2012.
74. Yang Y., Qiu X.Q., Yu H.P., Zeng X.Y., Bei C.H. TNF-alpha-863 polymorphisms and the risk of hepatocellular carcinoma. Exp. Ther. Med. 2012, 3:513-518.
75. Xu Y., Liu Y., Pan S., Liu L., Liu J., Zhai X., Shen H., Hu Z. IL-23R polymorphisms, HBV infection, and risk of hepatocellular carcinoma in a high-risk Chinese population. J. Gastroenterol. 2013, 48:125-131.
76. Jiang L., Xu J., Ni J., Gao X., Zhu Z., Dong D., Wang X., Shi C., Tao X., Dong W., Gao Y. A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population. DNA Cell Biol. 2012, 31:1480-1485.
77. Liu Y., Zhang Y., Wen J., Liu L., Zhai X., Liu J., Pan S., Chen J., Shen H., Hu Z. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One 2012, 7:e32230.
78. Zhang J., Pan L., Chen L., Feng X., Zhou L., Zheng S. Non-classical MHC-Iota genes in chronic hepatitis B and hepatocellular carcinoma. Immunogenetics 2012, 64:251-258.
79. Kim Y.S., Cheong J.Y., Cho S.W., Lee K.M., Hwang J.C., Oh B., Kimm K., Lee J.A., Park B.L., Cheong H.S., Shin H.D., Kim J.H. A functional SNP of the Interleukin-18 gene is associated with the presence of hepatocellular carcinoma in hepatitis B virus-infected patients. Dig. Dis. Sci. 2009, 54:2722-2728.
80. Gu X., Qi P., Zhou F., Ji Q., Wang H., Dou T., Zhao Y., Gao C. +49G>A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population. Hum. Immunol. 2010, 71:83-87.
81. Zhang H., Zhai Y., Hu Z., Wu C., Qian J., Jia W., Ma F., Huang W., Yu L., Yue W., Wang Z., Li P., Zhang Y., Liang R., Wei Z., Cui Y., Xie W., Cai M., Yu X., Yuan Y., Xia X., Zhang X., Yang H., Qiu W., Yang J., Gong F., Chen M., Shen H., Lin D., Zeng Y.X., He F., Zhou G. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat. Genet. 2010, 42:755-758.
82. Li S., Qian J., Yang Y., Zhao W., Dai J., Bei J.X., Foo J.N., McLaren P.J., Li Z., Yang J., Shen F., Liu L., Pan S., Wang Y., Li W., Zhai X., Zhou B., Shi L., Chen X., Chu M., Yan Y., Wang J., Cheng S., Shen J., Jia W., Liu J., Wen Z., Li A., Zhang Y., Zhang G., Luo X., Qin H., Chen M., Wang H., Jin L., Lin D., Shen H., He L., de Bakker P.I., Zeng Y.X., Wu M., Hu Z., Shi Y., Zhou W. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet. 2012, 8:e1002791.
83. Jiang D.K., Sun J., Cao G., Liu Y., Lin D., Gao Y.Z., Ren W.H., Long X.D., Zhang H., Ma X.P., Wang Z., Jiang W., Chen T.Y., Gao Y., Sun L.D., Long J.R., Huang H.X., Wang D., Yu H., Zhang P., Tang L.S., Peng B., Cai H., Liu T.T., Zhou P., Liu F., Lin X., Tao S., Wan B., Sai-Yin H.X., Qin L.X., Yin J., Liu L., Wu C., Pei Y., Zhou Y.F., Zhai Y., Lu P.X., Tan A., Zuo X.B., Fan J., Chang J., Gu X., Wang N.J., Li Y., Liu Y.K., Zhai K., Hu Z., Liu J., Yi Q., Xiang Y., Shi R., Ding Q., Zheng W., Shu X.O., Mo Z., Shugart Y.Y., Zhang X.J., Zhou G., Shen H., Zheng S.L., Xu J., Yu L. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat. Genet. 2013, 45:72-75.
84. Sopipong W., Tangkijvanich P., Payungporn S., Posuwan N., Poovorawan Y. The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in thai patients. Asian Pac. J. Cancer Prev. 2013, 14:2865-2869.
85. Yang P., Li Q.J., Feng Y., Zhang Y., Markowitz G.J., Ning S., Deng Y., Zhao J., Jiang S., Yuan Y., Wang H.Y., Cheng S.Q., Xie D., Wang X.F. TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell. 2012, 22:291-303.
86. Zhang H.H., Mei M.H., Fei R., Liu F., Wang J.H., Liao W.J., Qin L.L., Wei L., Chen H.S. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. J. Viral. Hepat. 2010, 17(Suppl. 1):34-43.
87. Meindl-Beinker N.M., Matsuzaki K., Dooley S. TGF-beta signaling in onset and progression of hepatocellular carcinoma. Dig. Dis. 2012, 30:514-523.
88. Roderburg C., Gautheron J., Luedde T. TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?. Dig. Dis. 2012, 30:500-507.
89. Gao B., Wang H., Lafdil F., Feng D. STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J. Hepatol. 2012, 57:430-441.
90. Tian Y., Yang W., Song J., Wu Y., Ni B. HBV X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol. Cell. Biol. 2013.
91. Liu Y., Zhao J.J., Wang C.M., Li M.Y., Han P., Wang L., Cheng Y.Q., Zoulim F., Ma X., Xu D.P. Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chin. Med. J. (Engl) 2009, 122:10-14.
92. Yang L., Ma Z., Wang D., Zhao W., Chen L., Wang G. MicroRNA-602 regulating tumor suppressive gene RASSF1A is over-expressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol. Ther. 2010, 9:803-808.
93. Zhang X., Liu S., Hu T., He Y., Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009, 50:490-499.
94. Kong G., Zhang J., Zhang S., Shan C., Ye L., Zhang X. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 2011, 6:e19518.
95. Yuan K., Lian Z., Sun B., Clayton M.M., Ng I.O., Feitelson M.A. Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One 2012, 7:e35331.
96. Bui-Nguyen T.M., Pakala S.B., Sirigiri D.R., Martin E., Murad F., Kumar R. Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J. Biol. Chem. 2010, 285:6980-6986.
97. Place R.F., Li L.C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. USA 2008, 105:1608-1613.
98. Huang J., Wang Y., Guo Y., Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010, 52:60-70.
99. Wu G., Yu F., Xiao Z., Xu K., Xu J., Tang W., Wang J., Song E. Hepatitis B virus X protein down-regulates expression of the miR-16 family in malignant hepatocytes in vitro. Br. J. Cancer 2011, 105:146-153.
100. Liu W.H., Yeh S.H., Chen P.J. Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochim. Biophys. Acta 1809, 2011:678-685.